Avivagen Inc. (VIVXF) Research

Avivagen Inc. is a life sciences firm primarily engaged in creating and distributing specialized feed supplements for livestock. These products are designed to bolster animals' immune function and contribute to their enhanced growth and overall productivity. The company's diverse product portfolio includes OxC-beta Livestock, a key additive for animal feeds, alongside canine wellness offerings such as Vivamune and Dr. Tobias dog chews. Furthermore, Avivagen provides the Dr. Tobias Beta blend, formulated to support the human immune system. With a significant international footprint, Avivagen serves customers across the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. The company was established in 2005 and is headquartered in Ottawa, Canada.

Market snapshot

Symbol
VIVXF
Price
$0.00
Day change
0.00%
Market cap
$776.9K
P/E ratio
-0.11x
52-week range
0.0001-0.0012
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
16 hours ago

Peer companies

  • Aoxing Pharmaceutical Company, Inc. (AOXG)
  • CannAmerica Brands Corp. (CNNXF)
  • Plant-Based Investment Corp. (CWWBF)
  • 4Front Ventures Corp. (FFNTF)
  • Global Hemp Group Inc. (GBHPF)
  • HempAmericana, Inc (HMPQ)
  • Industry Source Consulting, Inc. (INSO)
  • Pazoo, Inc. (PZOO)

Open Avivagen Inc. (VIVXF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.